Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |